The Biodistribution of 1-L-(2 Deoxy-2,- 18 Fluoroarabinofuranosyl) Cytosine ([18F]L-FAC) in Healthy Subjects and Patients With Cancer, Autoimmune and Inflammatory Diseases
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01180868 |
Recruitment Status :
Completed
First Posted : August 12, 2010
Last Update Posted : July 31, 2012
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Autoimmune Diseases Cancer |
Study Type : | Observational |
Actual Enrollment : | 1 participants |
Official Title: | The Biodistribution of 1-L-(2 Deoxy-2,- 18 Fluoroarabinofuranosyl) Cytosine ([18F]L-FAC) in Healthy Subjects and Patients With Cancer, Autoimmune and Inflammatory Diseases |
Study Start Date : | May 2008 |
Actual Primary Completion Date : | November 2011 |

Group/Cohort |
---|
patients with cancer
patients with hematological malignancies and solid tumors
|
patients with autoimmune dosorders
patients with Rheumatoid arthritis, Crohns's disease, systemic lupus erythematosus.
|
healthy subjects |

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- greater than 18 years of age
- women of childbearing potential will undergo a pregnancy test free of charge
- patients with hematological malignancies, solid tumors or autoimmune disorders

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01180868
United States, California | |
UCLA | |
Los Angeles, California, United States, 90095 |
Principal Investigator: | Christiaan Schiepers, M.D. Ph.D | University of California, Los Angeles |
Responsible Party: | Jonsson Comprehensive Cancer Center |
ClinicalTrials.gov Identifier: | NCT01180868 |
Other Study ID Numbers: |
08-02-049 DE-PS02-08ER08-01 ( Other Grant/Funding Number: Department of Energy ) CIRM No. RT1-01126-1 ( Other Grant/Funding Number: California Institute for Regenerative Medicine ) |
First Posted: | August 12, 2010 Key Record Dates |
Last Update Posted: | July 31, 2012 |
Last Verified: | July 2012 |
imaging probe cancer inflammatory tissue inflammatory diseases |
Autoimmune Diseases Immune System Diseases |